scholarly article | Q13442814 |
P356 | DOI | 10.1089/OMI.2011.0012 |
P953 | full work available at URL | http://www.liebertpub.com/doi/full-xml/10.1089/omi.2011.0012 |
http://www.liebertpub.com/doi/pdf/10.1089/omi.2011.0012 | ||
https://doi.org/10.1089/omi.2011.0012 | ||
https://europepmc.org/articles/PMC3166183 | ||
https://europepmc.org/articles/pmc3166183?pdf=render | ||
https://europepmc.org/articles/PMC3166183?pdf=render | ||
P932 | PMC publication ID | 3166183 |
P698 | PubMed publication ID | 21815811 |
P5875 | ResearchGate publication ID | 51546415 |
P50 | author | Richard B Kennedy | Q97591233 |
Gregory A. Poland | Q22096751 | ||
P2860 | cites work | Journal of Clinical Investigation | Q3186904 |
Identification of a universal Group B streptococcus vaccine by multiple genome screen | Q34313096 | ||
Systems vaccinology | Q34402910 | ||
Stunned silence: gene expression programs in human cells infected with monkeypox or vaccinia virus | Q34498815 | ||
Antibody profiling by proteome microarray reveals the immunogenicity of the attenuated smallpox vaccine modified vaccinia virus ankara is comparable to that of Dryvax | Q36424513 | ||
Next-generation sequencing: applications beyond genomes | Q36928719 | ||
Heterogeneity in vaccine immune response: the role of immunogenetics and the emerging field of vaccinomics | Q36986515 | ||
Loss-of-function variants in endothelial lipase are a cause of elevated HDL cholesterol in humans | Q37143381 | ||
Bioinformatics approaches for genomics and post genomics applications of next-generation sequencing | Q37623244 | ||
Personalized dendritic cell-based tumor immunotherapy | Q37693733 | ||
Immunoinformatics and systems biology methods for personalized medicine | Q37786271 | ||
Vaccines and the future of human immunology | Q37804529 | ||
Integrated analysis of ATM mediated gene and protein expression impacting cellular metabolism. | Q39591869 | ||
Single nucleotide polymorphisms in genes for 2'-5'-oligoadenylate synthetase and RNase L inpatients hospitalized with West Nile virus infection | Q40495949 | ||
Infection of mouse neurones by West Nile virus is modulated by the interferon-inducible 2'-5' oligoadenylate synthetase 1b protein | Q40558923 | ||
ASSIMILATOR: a new tool to inform selection of associated genetic variants for functional studies | Q41433486 | ||
Vaccinomics, Predictive Vaccinology And The Future of Vaccine Development | Q51772775 | ||
Pharmacology, vaccinomics, and the second golden age of vaccinology | Q53169887 | ||
Personalized vaccines: the emerging field of vaccinomics | Q57157844 | ||
Gene expression profiling of monkeypox virus-infected cells reveals novel interfaces for host-virus interactions | Q21245114 | ||
A physical and regulatory map of host-influenza interactions reveals pathways in H1N1 infection | Q24294658 | ||
Trends affecting the future of vaccine development and delivery: the role of demographics, regulatory science, the anti-vaccine movement, and vaccinomics | Q24648874 | ||
A nonsense mutation in the gene encoding 2'-5'-oligoadenylate synthetase/L1 isoform is associated with West Nile virus susceptibility in laboratory mice | Q27471916 | ||
Genetic Variation in OAS1 Is a Risk Factor for Initial Infection with West Nile Virus in Man | Q27487937 | ||
Sequencing technologies - the next generation | Q27860568 | ||
Is systems biology the key to preventing the next pandemic? | Q28473401 | ||
Computational solutions to large-scale data management and analysis | Q28743172 | ||
Systems integration of biodefense omics data for analysis of pathogen-host interactions and identification of potential targets | Q28751538 | ||
Systems biology of innate immunity | Q28752485 | ||
Systems biology approach predicts immunogenicity of the yellow fever vaccine in humans | Q29616204 | ||
An interferon-inducible neutrophil-driven blood transcriptional signature in human tuberculosis | Q29618105 | ||
Applications of next-generation sequencing technologies in functional genomics | Q29619225 | ||
Influenza A viruses: why focusing on M2e-based universal vaccines | Q30396318 | ||
InnateDB: facilitating systems-level analyses of the mammalian innate immune response. | Q30484002 | ||
Proteomic basis of the antibody response to monkeypox virus infection examined in cynomolgus macaques and a comparison to human smallpox vaccination. | Q30994031 | ||
SNPs in Multi-species Conserved Sequences (MCS) as useful markers in association studies: a practical approach | Q33293455 | ||
Next-generation sequencing: a transformative tool for vaccinology | Q33744262 | ||
Systems biology of interstitial lung diseases: integration of mRNA and microRNA expression changes | Q33795193 | ||
Vaccinomics and bioinformatics: accelerants for the next golden age of vaccinology | Q33814924 | ||
Integration of lipidomics and transcriptomics data towards a systems biology model of sphingolipid metabolism | Q33814929 | ||
Variation in antiviral 2',5'-oligoadenylate synthetase (2'5'AS) enzyme activity is controlled by a single-nucleotide polymorphism at a splice-acceptor site in the OAS1 gene | Q33942146 | ||
Simultaneous high-resolution analysis of vaccinia virus and host cell transcriptomes by deep RNA sequencing | Q33953053 | ||
The art of the probable: system control in the adaptive immune system | Q34307986 | ||
P433 | issue | 9 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 533-537 | |
P577 | publication date | 2011-08-04 | |
P13046 | publication type of scholarly work | review article | Q7318358 |
P1433 | published in | OMICS A Journal of Integrative Biology | Q15753054 |
P1476 | title | The top five "game changers" in vaccinology: toward rational and directed vaccine development | |
The Top Five “Game Changers” in Vaccinology: Toward Rational and Directed Vaccine Development | |||
P478 | volume | 15 |
Q28074461 | Anaplasma marginale: Diversity, Virulence, and Vaccine Landscape through a Genomics Approach |
Q37443100 | Comparison of the live attenuated yellow fever vaccine 17D-204 strain to its virulent parental strain Asibi by deep sequencing |
Q42040401 | Coping with genetic diversity: the contribution of pathogen and human genomics to modern vaccinology |
Q97519043 | Current Challenges in Vaccinology |
Q55314046 | Emergence of Leptin in Infection and Immunity: Scope and Challenges in Vaccines Formulation. |
Q26782451 | Enhancing vaccine safety capacity globally: A lifecycle perspective |
Q38140041 | Exploitation of physiology and metabolomics to identify pneumococcal vaccine candidates |
Q30951944 | High-throughput data analysis and data integration for vaccine trials |
Q41901935 | Host defense pathways against fungi: the basis for vaccines and immunotherapy |
Q36680938 | Leptin-based adjuvants: An innovative approach to improve vaccine response |
Q30366743 | Molecular mechanisms for enhanced DNA vaccine immunogenicity. |
Q41996442 | Successes and failures in human tuberculosis vaccine development. |
Q38075096 | Systems approach to tuberculosis vaccine development |
Q39759401 | The composition of immune cells serves as a predictor of adaptive immunity in a cohort of 50- to 74-year-old adults |
Q36438236 | The future of human DNA vaccines |
Q36603325 | The genetic basis for interindividual immune response variation to measles vaccine: new understanding and new vaccine approaches |
Q38186857 | The link between genetic variation and variability in vaccine responses: systematic review and meta-analyses |
Q51416013 | Vaccines Meet Big Data: State-of-the-Art and Future Prospects. From the Classical 3Is ("Isolate-Inactivate-Inject") Vaccinology 1.0 to Vaccinology 3.0, Vaccinomics, and Beyond: A Historical Overview. |
Q21089599 | Vaccines: From Empirical Development to Rational Design |
Q24261399 | Vaccinology in the third millennium: scientific and social challenges |
Q48420180 | Vaccinology: The name, the concept, the adjectives |
Q37119456 | Vaccinomics, adversomics, and the immune response network theory: individualized vaccinology in the 21st century |
Q36373260 | Variability in Humoral Immunity to Measles Vaccine: New Developments |
Q36733384 | Variation between Populations in the Innate Immune Response to Vaccine Adjuvants |
Search more.